Centric Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Centric Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,180	Closed	-$1.99M	–	154
2021 Q2	$1.99M	Sell	11,180 -330	-3%	-$57.2K	0.69%	33
2021 Q1	$1.89M	Sell	11,510 -74	-0.6%	-$12.2K	0.54%	50
2020 Q4	$1.91M	Buy	11,584 +4,632	+67%	+$690K	0.6%	44
2020 Q3	$865K	Sell	6,952 -2,838	-29%	-$352K	0.65%	42
2020 Q2	$1.08M	Buy	9,790 +2,838	+41%	+$314K	0.57%	50
2020 Q1	$865K	Sell	6,952 -730	-10%	-$94.4K	0.65%	42
2019 Q4	$1.15M	Buy	7,682 +730	+11%	+$99.3K	0.91%	32
2019 Q3	$865K	Buy	6,952 +751	+12%	+$101K	0.65%	42
2019 Q2	$884K	Buy	+6,201	New	+$833K	0.77%	36

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Centric Wealth Management's JAZZ Position: Q3 2021 in Review

Centric Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 11,180 shares — an estimated $1.99M sold.

Centric Wealth Management first reported a position in JAZZ in Q2 2019 and held it in 9 quarters. The position peaked at $1.99M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

Centric Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Centric Wealth Management sold 11,180 Jazz Pharmaceuticals shares in Q3 2021, an estimated $1.99M.
Centric Wealth Management first reported a position in Jazz Pharmaceuticals in Q2 2019 and held it in 9 quarters.
Centric Wealth Management's Jazz Pharmaceuticals position peaked at $1.99M in Q2 2021.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Centric Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.